Flagship Harbor Advisors LLC Has $3.78 Million Stake in UnitedHealth Group Incorporated $UNH

Flagship Harbor Advisors LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 68.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 12,113 shares of the healthcare conglomerate's stock after purchasing an additional 4,926 shares during the period. Flagship Harbor Advisors LLC's holdings in UnitedHealth Group were worth $3,779,000 as of its most recent filing with the Securities and Exchange Commission.

• Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Caitlin John LLC boosted its holdings in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after purchasing an additional 111 shares during the last quarter. Triumph Capital Management acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $1,324,000. Wealth Effects LLC increased its position in shares of UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after acquiring an additional 591 shares during the last quarter. Arlington Partners LLC acquired a new position in UnitedHealth Group during the second quarter valued at approximately $2,229,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. increased its position in shares of UnitedHealth Group by 14.6% during the 2nd quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 28,798 shares of the healthcare conglomerate's stock worth $8,984,000 after purchasing an additional 3,660 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. Robert W. Baird reaffirmed an "underperform" rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Leerink Partners set a $410.00 price objective on UnitedHealth Group and gave the company an "outperform" rating in a research note on Wednesday. Mizuho boosted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a report on Thursday, October 9th. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $395.64.

• UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 3.2%

UNH stock opened at $356.05 on Thursday. The business's fifty day moving average price is $342.00 and its two-hundred day moving average price is $331.00. The stock has a market capitalization of $322.47 billion, a price-to-earnings ratio of 18.58, a PEG ratio of 2.37 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85.

• Big Banks Are Setting the Tone as Earnings Season Kicks Off

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts' consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period last year, the firm earned $7.15 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

• Five stocks we like better than UnitedHealth Group
• Utilities Stocks Explained – How and Why to Invest in Utilities
• These 3 High-Momentum ETFs Are Riding the Tech Wave
• High Dividend REITs: Are They an Ideal Way to Diversify?
• Verizon Results Trigger Rebound in High-Yield Stock
• What is the Dow Jones Industrial Average (DJIA)?
• Picks & Shovels: Investing in the Physical Foundation of AI

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here